Esophageal reflux disease proton pump inhibitor therapy impact upon sleep disturbance

April 11, 2012

The use of proton pump inhibitors improves the sleep and daytime quality of life for sufferers of gastroesophageal reflux disease, according to a systematic literature review in the April 2012 issue of Otolaryngology–Head and Neck Surgery.

A 2003 Gallup survey linked gastresophageal heartburn with frequent . (PPIs) have proven to be an effective treatment therapy and there are established criteria for treating reflux. However, there are no well-established clinical guidelines on how to treat the sleep disturbances with the resulting quality of life issues.

The review's objective was to evaluate the "impact of PPI treatment of on sleep disturbance—related outcomes."

The authors performed a systematic literature review in PubMed, Web of Science, and the Cochrane Library of all randomized placebo-controlled clinical trials from 1989 (when omeprazole became available) to October 2011. Additional relevant publications were identified based on the articles' citations.

The search strategy identified all randomized placebo-controlled clinical trials published in English; both inhibitor use and outcome measures of sleep disturbance were reported for esophageal reflux disease patients. Using a preestablished systematic review protocol and data extraction format, four coauthors independently reviewed all articles.

Based on the review findings, the authors state: "The existing evidence supports the use of PPI medications as a treatment to improve esophageal reflux disease symptoms and associated sleep disturbance-related outcomes."

"Although the improvements are likely secondary gains from reduction or elimination of nocturnal GERD symptoms, further research appears warranted to evaluate PPI treatment impact on polysomnography outcomes, as well as to examine the relationship of polysomnography vs. nonpolysomnography outcomes, for GERD patients with sleep disturbance and sleep-disordered breathing," they added.

Explore further: Heartburn controlled with step down to once daily therapy

More information: "Esophageal Reflux Disease Proton Pump Inhibitor Therapy Impact upon Sleep Disturbance: A Systematic Review", Otolaryngology–Head and Neck Surgery.

Related Stories

Heartburn controlled with step down to once daily therapy

February 27, 2012

(HealthDay) -- The majority of gastroesophageal reflux disease (GERD) patients who take twice-daily proton pump inhibitor (PPI) therapy, are able to successfully step down to management of heartburn with a daily dose of dexlansoprazole ...

Acid reflux drug does not improve asthma in children

January 24, 2012

Children without symptoms of gastroesophageal reflux whose asthma was being poorly controlled with anti-inflammatory treatment did not have an improvement in symptoms or lung function with the added treatment of the proton ...

Recommended for you

Study finds mixed results for use of mesh for hernia repair

October 18, 2016

Among patients undergoing incisional hernia repair, the use of mesh to reinforce the repair was associated with a lower risk of hernia recurrence over 5 years compared with when mesh was not used, although with long-term ...

Traditional surgery style worthwhile, says piles trial

October 10, 2016

Results of a five year trial on haemorrhoids (commonly known as piles), jointly sponsored by NHS Highland and the University of Aberdeen, have this week been published in The Lancet, one of the world's oldest and best known ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.